Home / Doxorubicin / Austria
AT ATC L01DB01 · updated 2 Nov 2026
Doxorubicin shortage in Austria
Is there a Doxorubicin shortage in Austria?
Yes. As of 2 Nov 2026, 1 Doxorubicin product is reported short in Austria, the first since 9 Sep 2026. The company estimate for the return is 31 Dec 2026. Main reason: quality problem or recall.
Also short in Canada, Germany, Italy, Ireland, Belgium, Czechia, Sweden. All countries.
Affected products in Austria
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| AT | Caelyx 2 mg/ml Konzentrat zur Herstellung einer Infusionslösung, 1 Stück limited | Baxter Holding B.V. | 9 Sep 2026 | 31 Dec 2026 | Quality problem or recall Qualitätsprobleme bei der Herstellung |
Source
BASG (Austrian Federal Office for Safety in Health Care). Official list. All reported restrictions, listed per pack (PZN).